HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Localisation of the gene responsible for fechtner syndrome in a region <600 Kb on 22q11-q13.

Abstract
Fechtner syndrome is an autosomal dominant disorder which has been thought to be a variant of Alport syndrome. It is characterised by nephritis, sensorineural hearing loss and eye abnormalities, as well as by macrothrombocytopenia and polymorphonuclear inclusion bodies. Recently, the Fechtner syndrome has been mapped in a 5.5 Mb region on the long arm of chromosome 22 by linkage analysis in an extended Israeli family. We describe here the genetic refinement of the Fechtner critical interval to a region less than 600 Kb by linkage analysis performed in a large Italian pedigree. The presence of several recombination events allowed the disease gene to be localised between markers D22S278 and D22S426, in a region containing only two non-recombinant markers, D22S1173 and D22S283. This interval, spanning <600 Kb on genomic DNA, has been entirely sequenced and contains six known and three putative genes.
AuthorsR Cusano, S Gangarossa, P Forabosco, G Caridi, G M Ghiggeri, G Russo, A Iolascon, R Ravazzolo, M Seri
JournalEuropean journal of human genetics : EJHG (Eur J Hum Genet) Vol. 8 Issue 11 Pg. 895-9 (Nov 2000) ISSN: 1018-4813 [Print] England
PMID11093280 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA
Topics
  • Abnormalities, Multiple (genetics, pathology)
  • Adult
  • Child
  • Chromosome Mapping
  • Chromosomes, Human, Pair 22 (genetics)
  • DNA (genetics)
  • Eye Abnormalities
  • Family Health
  • Female
  • Genotype
  • Haplotypes
  • Hearing Loss, Sensorineural
  • Humans
  • Italy
  • Male
  • Microsatellite Repeats
  • Middle Aged
  • Nephritis
  • Pedigree
  • Syndrome
  • Thrombocytopenia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: